Beauty Health Co/the (SKIN)

$1.97

-0.06

(-2.96%)

Market is closed - opens 7 PM, 17 Jun 2024

Insights on Beauty Health Co/the

  • Decreasing Revenue

    Revenue is down for the last 4 quarters, 117.5M → 81.40M (in $), with an average decrease of 11.2% per quarter

  • Increasing Net Profit

    Netprofit is up for the last 3 quarters, -73.8M → -679.0K (in $), with an average increase of 984.8% per quarter

  • Vs CL

    In the last 1 year, Colgate-palmolive Co. has given 23.2% return, outperforming this stock by 101.6%

  • Vs PG

    In the last 3 years, Procter & Gamble Company, The has given 13.6% return, outperforming this stock by 102.8%

Performance

  • $1.93
    $2.03
    $1.97
    downward going graph

    2.03%

    Downside

    Day's Volatility :4.93%

    Upside

    2.96%

    downward going graph
  • $1.35
    $9.21
    $1.97
    downward going graph

    31.47%

    Downside

    52 Weeks Volatility :85.34%

    Upside

    78.61%

    downward going graph

Returns

PeriodBeauty Health Co/theSector (Consumer Staples)Index (Russel 2000)
3 Months
-45.43%
1.9%
0.0%
6 Months
-30.88%
8.0%
0.0%
1 Year
-78.35%
3.2%
0.0%
3 Years
-89.16%
8.8%
-23.8%

Highlights

Market Capitalization
246.6M
Book Value
$0.51
Earnings Per Share (EPS)
-0.71
PEG Ratio
0.95
Wall Street Target Price
4.28
Profit Margin
-20.49%
Operating Margin TTM
-20.87%
Return On Assets TTM
-8.87%
Return On Equity TTM
-76.35%
Revenue TTM
393.1M
Revenue Per Share TTM
3.04
Quarterly Revenue Growth YOY
-5.7%
Gross Profit TTM
250.3M
EBITDA
-93.5M
Diluted Eps TTM
-0.71
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
-0.01
EPS Estimate Next Year
0.04
EPS Estimate Current Quarter
-0.14
EPS Estimate Next Quarter
-0.03

Analyst Recommendation

Hold
    16%Buy
    50%Hold
    33%Sell
Based on 18 Wall street analysts offering stock ratings for Beauty Health Co/the(by analysts ranked 0 to 5 stars)
Based on 18 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
3
3
3
Hold
9
9
9
Sell
6
6
6

Analyst Forecast

What analysts predicted

Upside of 117.26%

Current $1.97
Target $4.28

Company Financials

FY18Y/Y Change
Revenue
112.3M
-
Net Income
-317.0K
-
Net Profit Margin
-0.28%
-
FY19Y/Y Change
Revenue
166.6M
↑ 48.36%
Net Income
-1.6M
↑ 416.72%
Net Profit Margin
-0.98%
↓ 0.7%
FY20Y/Y Change
Revenue
119.1M
↓ 28.53%
Net Income
-29.2M
↑ 1681.14%
Net Profit Margin
-24.5%
↓ 23.52%
FY21Y/Y Change
Revenue
260.1M
↑ 118.39%
Net Income
-375.1M
↑ 1185.72%
Net Profit Margin
-144.22%
↓ 119.72%
FY22Y/Y Change
Revenue
365.9M
↑ 40.68%
Net Income
44.2M
↓ 111.79%
Net Profit Margin
12.09%
↑ 156.31%
FY23Y/Y Change
Revenue
398.0M
↑ 8.78%
Net Income
-100.1M
↓ 326.38%
Net Profit Margin
-25.16%
↓ 37.25%
Q4 FY22Q/Q Change
Revenue
98.1M
↑ 10.52%
Net Income
3.8M
↑ 2812.21%
Net Profit Margin
3.89%
↑ 3.74%
Q1 FY23Q/Q Change
Revenue
86.3M
↓ 12.06%
Net Income
-22.2M
↓ 681.91%
Net Profit Margin
-25.72%
↓ 29.61%
Q2 FY23Q/Q Change
Revenue
117.5M
↑ 36.15%
Net Income
3.4M
↓ 115.15%
Net Profit Margin
2.86%
↑ 28.58%
Q3 FY23Q/Q Change
Revenue
97.4M
↓ 17.11%
Net Income
-73.8M
↓ 2293.82%
Net Profit Margin
-75.77%
↓ 78.63%
Q4 FY23Q/Q Change
Revenue
96.8M
↓ 0.62%
Net Income
-9.4M
↓ 87.26%
Net Profit Margin
-9.71%
↑ 66.06%
Q1 FY24Q/Q Change
Revenue
81.4M
↓ 15.91%
Net Income
-679.0K
↓ 92.78%
Net Profit Margin
-0.83%
↑ 8.88%
FY19Y/Y Change
Total Assets
226.4M
-
Total Liabilities
227.6M
-
FY20Y/Y Change
Total Assets
222.8M
↓ 1.55%
Total Liabilities
252.8M
↑ 11.09%
FY21Y/Y Change
Total Assets
1.2B
↑ 446.95%
Total Liabilities
916.5M
↑ 262.55%
FY22Y/Y Change
Total Assets
1.0B
↓ 17.22%
Total Liabilities
837.4M
↓ 8.63%
FY23Y/Y Change
Total Assets
929.1M
↓ 7.91%
Total Liabilities
869.7M
↑ 3.86%
Q4 FY22Q/Q Change
Total Assets
1.0B
↓ 8.68%
Total Liabilities
837.4M
↓ 1.12%
Q1 FY23Q/Q Change
Total Assets
994.9M
↓ 1.39%
Total Liabilities
847.3M
↑ 1.18%
Q2 FY23Q/Q Change
Total Assets
1.0B
↑ 1.27%
Total Liabilities
845.6M
↓ 0.2%
Q3 FY23Q/Q Change
Total Assets
973.1M
↓ 3.41%
Total Liabilities
883.2M
↑ 4.45%
Q4 FY23Q/Q Change
Total Assets
929.1M
↓ 4.52%
Total Liabilities
869.7M
↓ 1.53%
Q1 FY24Q/Q Change
Total Assets
844.7M
↓ 9.08%
Total Liabilities
781.4M
↓ 10.15%
FY18Y/Y Change
Operating Cash Flow
-895.0K
-
Investing Cash Flow
-8.4M
-
Financing Cash Flow
11.2M
-
FY19Y/Y Change
Operating Cash Flow
1.7M
↓ 293.07%
Investing Cash Flow
-12.5M
↑ 47.81%
Financing Cash Flow
14.6M
↑ 30.58%
FY20Y/Y Change
Operating Cash Flow
-12.4M
↓ 819.68%
Investing Cash Flow
-3.8M
↓ 69.42%
Financing Cash Flow
18.3M
↑ 25.35%
FY21Y/Y Change
Operating Cash Flow
-28.4M
↑ 128.06%
Investing Cash Flow
-37.7M
↑ 888.5%
Financing Cash Flow
959.0M
↑ 5148.37%
FY22Y/Y Change
Operating Cash Flow
-106.6M
↑ 275.87%
Investing Cash Flow
-18.9M
↓ 49.99%
Financing Cash Flow
-205.2M
↓ 121.4%
Q4 FY22Q/Q Change
Operating Cash Flow
-5.4M
↓ 82.83%
Investing Cash Flow
-2.8M
↓ 63.52%
Financing Cash Flow
-102.5M
↑ 2.48%
Q1 FY23Q/Q Change
Operating Cash Flow
-13.0M
↑ 141.24%
Investing Cash Flow
-21.7M
↑ 667.85%
Financing Cash Flow
-2.2M
↓ 97.86%
Q2 FY23Q/Q Change
Operating Cash Flow
22.0M
↓ 268.84%
Investing Cash Flow
-3.2M
↓ 85.15%
Financing Cash Flow
-1.5M
↓ 29.57%

Technicals Summary

Sell

Neutral

Buy

Beauty Health Co/the is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Beauty Health Co/the
Beauty Health Co/the
-28.88%
-30.88%
-78.35%
-89.16%
-84.23%
Colgate-palmolive Co.
Colgate-palmolive Co.
0.1%
22.92%
23.2%
13.63%
28.89%
Estée Lauder Companies Inc.
Estée Lauder Companies Inc.
-16.25%
-20.7%
-42.88%
-62.39%
-35.87%
Procter & Gamble Company, The
Procter & Gamble Company, The
0.17%
15.86%
12.35%
23.87%
50.27%
Kenvue Inc.
Kenvue Inc.
-12.03%
-13.91%
-29.83%
-32.83%
-32.83%
Kimberly-clark Corp.
Kimberly-clark Corp.
4.01%
16.79%
2.33%
7.95%
1.67%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Beauty Health Co/the
Beauty Health Co/the
49.42
NA
0.95
-0.01
-0.76
-0.09
NA
0.51
Colgate-palmolive Co.
Colgate-palmolive Co.
30.08
30.08
2.15
3.53
0.53
0.16
0.02
0.28
Estée Lauder Companies Inc.
Estée Lauder Companies Inc.
63.99
63.99
1.6
2.24
0.1
0.03
0.02
16.02
Procter & Gamble Company, The
Procter & Gamble Company, The
27.25
27.25
3.28
6.55
0.32
0.11
0.02
20.87
Kenvue Inc.
Kenvue Inc.
23.17
23.17
2.11
1.14
0.1
0.06
0.04
5.55
Kimberly-clark Corp.
Kimberly-clark Corp.
25.59
25.59
1.57
7.13
1.81
0.11
0.04
3.1
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Beauty Health Co/the
Beauty Health Co/the
Hold
$246.6M
-84.23%
49.42
-20.49%
Colgate-palmolive Co.
Colgate-palmolive Co.
Buy
$77.7B
28.89%
30.08
13.22%
Estée Lauder Companies Inc.
Estée Lauder Companies Inc.
Hold
$40.9B
-35.87%
63.99
4.18%
Procter & Gamble Company, The
Procter & Gamble Company, The
Buy
$393.6B
50.27%
27.25
17.99%
Kenvue Inc.
Kenvue Inc.
Buy
$34.6B
-32.83%
23.17
9.63%
Kimberly-clark Corp.
Kimberly-clark Corp.
Hold
$47.0B
1.67%
25.59
9.05%

Institutional Holdings

  • FMR Inc

    15.90%
  • HHG PLC

    9.13%
  • Luxor Capital Group, LP

    5.51%
  • BlackRock Inc

    4.60%
  • Vanguard Group Inc

    4.50%
  • Divisadero Street Capital Management, LP

    3.94%

Company Information

The Beauty Health Co. engages in manufacturing and selling of serum-based hydradermabrasion systems and aesthetic products. The company was founded in 1997 and is headquartered in Long Beach, CA.

Organization
Beauty Health Co/the
Employees
881
CEO
Ms. Marla Malcolm Beck
Industry
Consumer/Non-Cyclical

FAQs